What is IXHL (IXHL) stock price today?

IXHL (IXHL) is currently trading at $3.18, down 5.07% today.

What is IXHL P/E ratio?

IXHL's P/E ratio is -0.09. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is IXHL return on equity (ROE)?

IXHL's return on equity (ROE) is -361.54%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is IXHL's market cap?

IXHL has a market capitalization of $38.05M.

NASDAQ · Drug Manufacturers - Specialty & Generic

IXHL (IXHL) Stock

$3.18 -5.07% NASDAQ: IXHL Healthcare

Valuation

Metric	Value
Price	$3.18
Market Cap	$38.05M
P/E Ratio	-0.09
P/B Ratio	3.28
P/S Ratio	495.45
EPS (TTM)	$-40.80
52-Week High	$49.80
52-Week Low	$2.49
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-361.54%
ROA	-235.00%
ROCE	-184.62%
Gross Margin	100.00%
Operating Margin	-379.21%
Net Margin	-646.30%
Debt/Equity	0.00
Current Ratio	2.86

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$1.0M	$0	$0	$0	$0
Operating Profit	$-9.0M	$-10.0M	$-14.0M	$-45.0M	$-24.0M
Net Profit	$-9.0M	$-10.0M	$-49.0M	$-28.0M	$-47.0M
EPS	$-1.05	$-1.04	$-9.51	$-3.42	$-40.80
Op Margin	-601.3%	—	—	-250341.7%	-27661.6%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$7.0M	$26.0M	$24.0M	$17.0M	$20.0M
Total Liabilities	$1.0M	$1.0M	$3.0M	$6.0M	$7.0M
Cash	$7.0M	$26.0M	$22.0M	$6.0M	$15.0M
Borrowings	$0	$0	$1.0M	$0	$0

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-5.0M	$-9.0M	$-11.0M	$-16.0M	$-13.0M
Investing Cash Flow	$0	$0	$-1.0M	$-1.0M	$0
Financing Cash Flow	$0	$-2.0M	$0	$0	$-25.0M
Net Cash Flow	$4.0M	$20.0M	$-4.0M	$-16.0M	$9.0M
Free Cash Flow	$-5.0M	$-9.0M	$-11.0M	$-16.0M	$-13.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-31.44%
Quick Ratio	48.27
Interest Coverage	—
Return 1Y	-68.19%
Return 3Y	-98.62%
Return 5Y	—

About IXHL

IXHL is led by CEO Joel Bradley Latham, employs 9 people, headquartered in AU, publicly traded since 2022.

IXHL stock trades at $3.18 with a market capitalization of $38.05M. The stock is valued at a price-to-earnings (P/E) ratio of -0.09, price-to-book of 3.28, price-to-sales of 495.45. Over the past 52 weeks the stock has ranged between $2.49 and $49.80, and currently trades 93.6% below its 52-week high.

On profitability, IXHL generates a return on equity (ROE) of -361.54%, return on capital employed of -184.62%, an operating margin of -379.21%, a net profit margin of -646.30%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides